Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine with sedative, hypnotic, anxiolytic, and anticonvulsant properties. It is primarily used for the management of anxiety disorders, insomnia, and status epilepticus.
## Primary Indications
* **Anxiety Disorders:** Short-term relief of anxiety symptoms.
* **Insomnia:** Short-term treatment of sleep disturbances.
* **Status Epilepticus:** First-line treatment for active seizures.
* **Premedication:** Sedation prior to medical procedures.
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally two to three times daily. Maximum daily dose is typically 10 mg.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously or intramuscularly. A second dose of 4 mg may be administered 5 to 10 minutes after the first dose if seizures persist.
* **Premedication:** 2 mg to 4 mg intramuscularly or intravenously 2 hours before procedure.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be individualized based on age, weight, and clinical condition. Specific dosing protocols should be followed.
* **Status Epilepticus:** 0.1 mg/kg intravenously or intramuscularly, not to exceed 4 mg per dose. A repeat dose of 0.05 mg/kg may be given after 5 to 10 minutes if needed.
* **Sedation/Anxiety:** Dosing is not well-established and requires careful titration under close medical supervision.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment is usually required, but caution is advised, especially in severe impairment.
## Contraindications
* Known hypersensitivity to benzodiazepines.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Acute narrow-angle glaucoma.
## Adverse Effects
Common adverse effects include drowsiness, dizziness, fatigue, ataxia, and confusion. Less common effects include paradoxical excitement, amnesia, and respiratory depression, particularly with parenteral administration or in combination with other CNS depressants.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Additive CNS depression, potentially leading to profound sedation, respiratory depression, coma, and death. Use concurrently is strongly discouraged; if unavoidable, limit dose and duration of concomitant use and monitor closely.
* **Theophylline, Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic acid:** May decrease lorazepam clearance and increase plasma concentrations.
## Monitoring
* **Sedation level:** Especially with parenteral administration or in elderly patients.
* **Respiratory rate and oxygen saturation:** Particularly during acute treatment or with co-administration of other respiratory depressants.
* **Cognitive function:** Assess for confusion or memory impairment.
* **Signs of dependence and withdrawal:** With prolonged use.
## Clinical Pearls
* Lorazepam has an intermediate half-life, making it suitable for various indications.
* Intramuscular absorption can be erratic; intravenous administration is preferred for faster onset of action, especially in emergencies.
* Elderly patients are more sensitive to the sedative and ataxic effects; start with lower doses and titrate cautiously.
* Abrupt discontinuation after prolonged use can lead to withdrawal symptoms. Taper the dose gradually.
* Avoid concurrent use with alcohol and other CNS depressants.
***
*Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for complete details before making any treatment decisions.*
